Comorbid addictive disorders and schizophrenia in the aspect of pathogenesis and treatment

被引：0
作者：
Eryshev, O. F. [1 ]
Arkad'ev, V. V. [1 ]
机构：
[1] VM Bekhterev Psychoneurol Res Inst, St Petersburg, Russia
来源：
ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA | 2010年 / 110卷 / 05期
关键词：
addictive disorders; schizophrenia; comorbidity; biochemical mechanisms; neuroleptics; SUBSTANCE USE DISORDERS; NMDA RECEPTOR HYPOFUNCTION; PREFRONTAL CORTEX; DOPAMINE SYSTEM; WORKING-MEMORY; CANNABIS USE; DRUG-ABUSE; ALCOHOL; CLOZAPINE; GLUTAMATE;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Combinations of schizophrenia with addictive disorders are common in clinical practice. Some hypotheses were posited to explain this phenomenon with the biochemical hypothesis being the most common. A vast body of evidence supports the similarity in the pathogenesis of addiction and schizophrenia. Biochemical data on the pathogenesis of both diseases are used for treatment recommendations. However there are many discrepancies in this field and future research is needed.
引用
收藏
页码：67 / 73
页数：7
相关论文
共 50 条
  • [11] Combination of olanzapine with opioid-agonists in the treatment of heroin-addicted patients affected by comorbid schizophrenia spectrum disorders
    Gerra, Gilberto
    Di Petta, Gilberto
    D'Amore, Antonio
    Iannotta, Pasquale
    Bardicchia, Francesco
    Falorni, Fabio
    Coacci, Alessandro
    Strepparola, Giovanni
    Campione, Guglielmo
    Lucchini, Alfio
    Vedda, Giuseppina
    Serio, Giorgio
    Manzato, Ezio
    Antonioni, Maina
    Bertacca, Simone
    Moi, Gabriele
    Zaimovic, Amir
    CLINICAL NEUROPHARMACOLOGY, 2007, 30 (03) : 127 - 135
  • [12] Treatment With Acamprosate in Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence
    Ralevski, Elizabeth
    O'Brien, Erin
    Jane, J. Serrita
    Dwan, Rita
    Dean, Erica
    Edens, Ellen
    Arnaout, Bachaar
    Keegan, Kathryn
    Drew, Shannon
    Petrakis, Ismene
    JOURNAL OF DUAL DIAGNOSIS, 2011, 7 (1-2) : 64 - 73
  • [13] Comorbid anxiety disorders in patients with schizophrenia
    Vrbova, Kristyna
    Prasko, Jan
    Kamaradova, Dana
    Cerna, Monika
    Ociskova, Marie
    Latalova, Klara
    Sedlackova, Zuzana
    ACTIVITAS NERVOSA SUPERIOR REDIVIVA, 2013, 55 (1-2): : 40 - 46
  • [14] Effects of Acamprosate on Cognition in a Treatment Study of Patients With Schizophrenia Spectrum Disorders and Comorbid Alcohol Dependence
    Ralevski, Elizabeth
    O'Brien, Erin
    Jane, J. Serrita
    Dean, Erica
    Dwan, Rita
    Petrakis, Ismene
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2011, 199 (07) : 499 - 505
  • [15] Benefit-Risk Assessment of Atypical Antipsychotics in the Treatment of Schizophrenia and Comorbid Disorders in Children and Adolescents
    Paz Toren
    Sharon Ratner
    Nathaniel Laor
    Abraham Weizman
    Drug Safety, 2004, 27 : 1135 - 1156
  • [16] Treatment of substance use disorders in schizophrenia
    Bennett, Melanie E.
    Bradshaw, Kristen R.
    Catalano, Lauren T.
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2017, 43 (04) : 377 - 390
  • [17] Difficulties in treatment of people with comorbid gambling and substance use disorders
    Wieczorek, Lukasz
    Dabrowska, Katarzyna
    JOURNAL OF SUBSTANCE USE, 2020, 25 (04) : 350 - 356
  • [18] Glutamate-Mediated Excitotoxicity in the Pathogenesis and Treatment of Neurodevelopmental and Adult Mental Disorders
    Nicosia, Noemi
    Giovenzana, Mattia
    Misztak, Paulina
    Mingardi, Jessica
    Musazzi, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [19] Pharmacological Interventions for Impulsivity in Addictive Disorders
    Schwartz, Elizabeth K. C.
    Palmisano, Alexandra N. N.
    Sofuoglu, Mehmet
    CURRENT ADDICTION REPORTS, 2023, 10 (02) : 149 - 165
  • [20] Pharmacological treatment of schizophrenia with comorbid substance use disorder
    Azorin, Jean-Michel
    Simon, Nicolas
    Adida, Marc
    Belzeaux, Raoul
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (02) : 231 - 253
12345